• Tue, March 31, 2020

by: WOPRAI

Michael Baker Maintained (ULTA) at Hold with Decreased Target to $190 on, Mar 31st, 2020

by: WOPRAI

Michael Rehaut Maintained (WHR) at Buy with Decreased Target to $100 on, Mar 31st, 2020

by: WOPRAI

Ravi Misra Downgraded (TDOC) to Hold on, Mar 31st, 2020

by: WOPRAI

Timna Tanners Reiterated (TECK) at Hold with Decreased Target to $8.5 on, Mar 31st, 2020

by: WOPRAI

Adam Gonzalez Upgraded (CRUS) to Strong Buy on, Mar 31st, 2020

by: WOPRAI

Sarah Akers Maintained (CNP) at Hold with Decreased Target to $18 on, Mar 31st, 2020

by: WOPRAI

Bryan Keane Maintained (WU) at Hold with Decreased Target to $20 on, Mar 31st, 2020

by: WOPRAI

Richard Radbourne Downgraded (XYL) to Hold and Held Target at $75 on, Mar 31st, 2020

by: WOPRAI

Mark May Maintained (YELP) at Hold with Decreased Target to $21 on, Mar 31st, 2020

by: WOPRAI

Garrett Nelson Upgraded (BWA) to Strong Buy and Held Target at $35 on, Mar 31st, 2020

by: WOPRAI

Pamela Kaufman Maintained (BRBR) at Buy with Decreased Target to $21 on, Mar 31st, 2020

by: WOPRAI

Benjamin Theurer Maintained (BRFS) at Buy with Decreased Target to $4.5 on, Mar 31st, 2020

by: WOPRAI

Lloyd Byrne Maintained (BRY) at Strong Buy with Decreased Target to $4.5 on, Mar 31st, 2020

by: WOPRAI

Michael Yee Downgraded (AMRN) to Hold and Decreased Target to $4 on, Mar 31st, 2020

by: WOPRAI

Paul Choi Downgraded (AMRN) to Hold and Decreased Target to $4 on, Mar 31st, 2020

by: WOPRAI

Leland Gershell Upgraded (AMRN) to Hold on, Mar 31st, 2020

by: WOPRAI

Derek Archila Maintained (AMRN) at Hold with Decreased Target to $8 on, Mar 31st, 2020

by: WOPRAI

Mitra Ramgopal Upgraded (AMN) to Strong Buy and Decreased Target to $74 on, Mar 31st, 2020

by: WOPRAI

Lloyd Byrne Upgraded (APA) to Hold and Decreased Target to $4.5 on, Mar 31st, 2020

by: WOPRAI

Joseph Mondillo Maintained (ALG) at Strong Buy with Decreased Target to $110 on, Mar 31st, 2020

by: WOPRAI

Ben Bienvenu Reiterated (CALM) at Buy with Increased Target to $55 on, Mar 31st, 2020

by: WOPRAI

Jeff Farmer Upgraded (CAKE) to Strong Buy on, Mar 31st, 2020

by: WOPRAI

Louie DiPalma Initiated (CACI) at Buy on, Mar 31st, 2020

by: WOPRAI

Arun Sundaram Reiterated (CAG) at Strong Buy with Increased Target to $35 on, Mar 31st, 2020

by: WOPRAI

David Anderson Maintained (BYND) at Buy with Decreased Target to $100 on, Mar 31st, 2020

by: WOPRAI

Naved Khan Maintained (CARG) at Strong Buy with Decreased Target to $33 on, Mar 31st, 2020

by: WOPRAI

Timothy Thein Maintained (CAT) at Strong Buy with Decreased Target to $125 on, Mar 31st, 2020

by: WOPRAI

Brian Bedell Maintained (CBOE) at Strong Buy with Decreased Target to $138 on, Mar 31st, 2020

by: WOPRAI

James Sheehan Maintained (CBT) at Strong Buy with Decreased Target to $35 on, Mar 31st, 2020

by: WOPRAI

Pauline Bell Maintained (ZION) at Hold with Decreased Target to $30 on, Mar 31st, 2020

by: WOPRAI

Michael Baker Maintained (BBY) at Hold with Decreased Target to $58 on, Mar 31st, 2020

by: WOPRAI

Brian Bedell Maintained (BEN) at Hold with Decreased Target to $19 on, Mar 31st, 2020

by: WOPRAI

Michael Rehaut Maintained (BECN) at Sell with Decreased Target to $16 on, Mar 31st, 2020

by: WOPRAI

Esther Rajavelu Maintained (BHVN) at Hold with Decreased Target to $37 on, Mar 31st, 2020

by: WOPRAI

Brian Bedell Maintained (AMG) at Hold with Decreased Target to $58 on, Mar 31st, 2020

by: WOPRAI

Alexander Paris Maintained (AMG) at Buy with Decreased Target to $70 on, Mar 31st, 2020

by: WOPRAI

Edward White Maintained (ALRN) at Strong Buy with Decreased Target to $60 on, Mar 31st, 2020

by: WOPRAI

Jane Trotsenko Downgraded (AR) to Hold and Decreased Target to $1 on, Mar 31st, 2020

by: WOPRAI

Matthew Luchini Initiated (APLS) at Buy and Held Target at $54 on, Mar 31st, 2020

by: WOPRAI

Lucas Pipes Maintained (ARLP) at Hold with Decreased Target to $6 on, Mar 31st, 2020

by: WOPRAI

Brent Bracelin Maintained (ADBE) at Buy with Decreased Target to $350 on, Mar 31st, 2020

by: WOPRAI

Weston Twigg Maintained (ADI) at Buy with Decreased Target to $120 on, Mar 31st, 2020

by: WOPRAI

Ben Kallo Maintained (ADM) at Buy with Increased Target to $41 on, Mar 31st, 2020

by: WOPRAI

Donald Fandetti Maintained (V) at Buy with Decreased Target to $205 on, Mar 31st, 2020

by: WOPRAI

Andrew Jeffrey Maintained (V) at Strong Buy with Decreased Target to $190 on, Mar 31st, 2020

by: WOPRAI

David Koning Maintained (V) at Buy with Increased Target to $175 on, Mar 31st, 2020

by: WOPRAI

Thiago Ojea Upgraded (VALE) to Strong Buy on, Mar 31st, 2020

by: WOPRAI

Brent Bracelin Maintained (VEEV) at Buy with Decreased Target to $180 on, Mar 31st, 2020

Matthew Luchini Initiated (APLS) at Buy and Held Target at $54 on, Mar 31st, 2020

Matthew Luchini of BMO Capital, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Buy and Held Target at $54 on, Mar 31st, 2020.

Matthew has made no other calls on APLS in the last 4 months.



There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Laura Chico of "Wedbush" Upgraded from Sell to Hold and Held Target at $29 on, Wednesday, March 11th, 2020
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $34 on, Monday, March 2nd, 2020


This is the rating of the analyst that currently disagrees with Matthew

  • Brian Cheng of "B of A Securities" Initiated at Strong Buy and Held Target at $36 on, Thursday, December 19th, 2019